(Q34911774)

5 August 2017

1 reference

title

Pegylated arginine deiminase: a novel anticancer enzyme agent (English)

1 reference

5 August 2017

1

Lynn Feun

1 reference

5 August 2017

Niramol Savaraj

2

1 reference

PubMed ID

16787144

5 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

Expert Opinion on Investigational Drugs

5 August 2017

1 reference

5 August 2017

15

1 reference

5 August 2017

815-822

1 reference

5 August 2017

7

1 reference

Identification of differentially expressed genes in clear cell renal cell carcinoma by analysis of full-length enriched cDNA library

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Arginine deprivation and metabolomics: important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Updated treatment approach to hepatocellular carcinoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Controlling cancer by restricting arginine availability--arginine-catabolizing enzymes as anticancer agents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Current concepts in the management of patients with melanoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Modulation of the pharmacokinetics and pharmacodynamics of proteins by polyethylene glycol conjugation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Prognosis of hepatocellular carcinoma: the BCLC staging classification

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Use of ?-asparaginase in childhood ALL

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Chemical modification by polyethylene glycol of the anti-tumor enzyme arginine deiminase from Mycoplasma arginini

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Anti-tumor activity of arginine deiminase from Mycoplasma argini and its growth-inhibitory mechanism

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

The Effects of Arginine Deficiency on Lymphoma Cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Arginine: biochemistry, physiology, and therapeutic implications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Tumor growth inhibitory activity of a lymphocyte blastogenesis inhibitory factor

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

High sensitivity of human melanoma cell lines to the growth inhibitory activity of mycoplasmal arginine deiminase in vitro

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: potentiation by irradiation.

8 July 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.7.815

Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.7.815

Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.7.815

Arginine deiminase enhances dexamethasone-induced cytotoxicity in human T-lymphoblastic leukemia CCRF-CEM cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.7.815

Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.7.815

Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.7.815

Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.7.815

Role of nitric oxide in IL-2 therapy-induced capillary leak syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.7.815

NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.7.815

Metastatic melanoma cells escape from immunosurveillance through the novel mechanism of releasing nitric oxide to induce dysfunction of immunocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.7.815

Regression of hepatocellular cancer in a patient treated with arginine deiminase

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor alpha and endotoxin

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086545

An arginine-deficient diet in humans does not evoke hyperammonemia or orotic aciduria

26 October 2018

1 reference

12 December 2020

Arginine deiminase inhibits cell proliferation by arresting cell cycle and inducing apoptosis

1 reference

12 December 2020

The arginine requirement of the infant

1 reference

12 December 2020

Amino acid requirements of man

1 reference

12 December 2020

Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis

1 reference

12 December 2020

10.1517/13543784.15.7.815

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

PubMed ID

16787144